Chris Dowd Chris Dowd

Chris Dowd is Senior Vice President, Market Development at ConnectiveRx. Chris has 25 years of pharma experience in sales, operations, managed care, and marketing positions, including Executive Director and VP levels in Pfizer, Esprit Pharma, and Allergan. Visit www.ConnectiveRx.com.

CBI’s 2018 Coupon and Copay Conference Delivers

This fall’s 6th Annual Coupon and Copay conference in Philadelphia provided multifaceted insight as ...

Changing Channels

According to data collected continuously since January 2010, patients are changing the ways they ...

The State of Copay

Patient out-of-pocket drug cost is a primary component of the medication adherence equation. Dr. ...

Breaking News: An On-the-Scene Report from CBI’s Coupon and Co-pay Conference

Since working with CBI to create the industry’s first co-pay summit back in 2013, ...

What’s So Great About Improving Medication Adherence?

Pharma brand managers deploy co-pay support programs for a host of reasons. Some of ...

Top Issues in Coupons and Co-pay: Focus on Payer Cost-shifting

Over the past several months we have seen several important developments in patient loyalty ...

The Dollars and Sense of Co-pay Assistance Programs

Over the past several months we’ve reviewed four of the five imperatives for coupon ...

How to Measure Co-pay Program Outcomes

Let’s get one thing straight from the get-go: Co-pay programs are not cleverly camouflaged ...

5 Maxims for Flawless Co-pay Program Execution

After working with dozens of pharmaceutical companies, hundreds of programs and millions of patient ...

Broadening Your Co-Pay Approach

PM360 Chris Dowd from PM360 Online on Vimeo. Pharma companies have seen the benefits ...

Channel Selection: The Second Step to Successful Co-pay Programs

The success of any co-pay assistance program is largely dependent on “the offer.” But ...

The No. 1 Imperative for All Co-pay Programs: The Offer

The success of any co-pay assistance program is largely dependent on “the offer.” That ...

Five Imperatives for Coupon and Co-pay Program Success

With 92% of covered workers now facing a tiered cost-sharing formulary for prescription drugs, ...